Pathological upgrading in prostate cancer patients eligible for active surveillance: Does prostate-specific antigen density matter?

PURPOSE: To evaluate prospectively the role of prostate-specific antigen (PSA) density in predicting Gleason score upgrading in prostate cancer patients eligible for active surveillance (T1/T2, biopsy Gleason score≤6, PSA≤10 ng/mL, and ≤2 positive biopsy cores). MATERIALS AND METHODS: Between Januar...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Byung-Soo, Kang, Seok-Hyun, Kim, Duk-Yoon, Oh, Hoon-Gyu, Kim, Chun-Il, Moon, Gi-Hak, Kwon, Tae-Gyun, Park, Jae-Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565896/
https://www.ncbi.nlm.nih.gov/pubmed/26366274
http://dx.doi.org/10.4111/kju.2015.56.9.624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565896/
https://www.ncbi.nlm.nih.gov/pubmed/26366274
http://dx.doi.org/10.4111/kju.2015.56.9.624

Ejemplares similares